I don't recall a date ever stated for a combo meeting. During some of the interviews NP said they had been in discussion about 525 vs 700 and sounded very confident / optimistic that FDA would accept 525. I have asked IR for clarification and have not received a response. I would think they would PR this once known, but if 525 is acceptable I expect the clinical portion of the BLA to be submitted very soon as NP previously stated Aug/Sep for clinical portion.